Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
B1272 FosaprepitantSummary: Neurokinin-1 antagonist
-
B2145 Fosaprepitant dimeglumine saltTarget: Neurokinin receptorSummary: Neurokinin-1 antagonist
-
A1684 AprepitantTarget: Substance P/NK1 ReceptorSummary: Substance P (SP) inhibitor
-
B6142 NetupitantSummary: neurokinin 1 (NK1) receptor antagonist
-
B5422 CP 99994 dihydrochlorideSummary: High affinity NK1 antagonist
-
B5510 SR 140333Summary: NK1 receptor antagonist
-
B6623 [Sar9,Met(O2)11]-Substance PSummary: NK1 tachykinin receptor agonist
-
B7039 SDZ NKT 343Summary: human tachykinin NK1 receptor antagonist
-
B7213 CP 96345Summary: NK1 receptor antagonist
-
B7565 L 760735Summary: NK1 receptor antagonist